199 related articles for article (PubMed ID: 31451675)
1. Mesenchymal Stem Cell-Derived Extracellular Vesicles Decrease Lung Injury in Mice.
Hao Q; Gudapati V; Monsel A; Park JH; Hu S; Kato H; Lee JH; Zhou L; He H; Lee JW
J Immunol; 2019 Oct; 203(7):1961-1972. PubMed ID: 31451675
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe
Park J; Kim S; Lim H; Liu A; Hu S; Lee J; Zhuo H; Hao Q; Matthay MA; Lee JW
Thorax; 2019 Jan; 74(1):43-50. PubMed ID: 30076187
[TBL] [Abstract][Full Text] [Related]
3. The impact of mesenchymal stem cells on host immunity and disease outcome in bacterial lung infection.
Stowell J; Reynolds C; Boyton R
Clin Med (Lond); 2020 Mar; 20(Suppl 2):s117-s118. PubMed ID: 32409419
[No Abstract] [Full Text] [Related]
4. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
Sengupta V; Sengupta S; Lazo A; Woods P; Nolan A; Bremer N
Stem Cells Dev; 2020 Jun; 29(12):747-754. PubMed ID: 32380908
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury.
Huang R; Qin C; Wang J; Hu Y; Zheng G; Qiu G; Ge M; Tao H; Shu Q; Xu J
Aging (Albany NY); 2019 Sep; 11(18):7996-8014. PubMed ID: 31575829
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive effects of mesenchymal stem cells on lung B cell gene expression in LPS-induced acute lung injury.
Feng B; Zhu J; Xu Y; Chen W; Sheng X; Feng X; Shi X; Liu J; Pan Q; Yang J; Yu J; Li L; Cao H
Stem Cell Res Ther; 2020 Sep; 11(1):418. PubMed ID: 32977837
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases.
Harrell CR; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 Dec; 8(12):. PubMed ID: 31835680
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
[No Abstract] [Full Text] [Related]
9. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome.
Han J; Liu Y; Liu H; Li Y
Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C
Zhu J; Feng B; Xu Y; Chen W; Sheng X; Feng X; Shi X; Liu J; Pan Q; Yu J; Li L; Cao H
Cell Death Dis; 2020 Oct; 11(10):829. PubMed ID: 33024074
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization.
Lv H; Liu Q; Sun Y; Yi X; Wei X; Liu W; Zhang Q; Yi H; Chen G
Ann Transl Med; 2020 Mar; 8(6):334. PubMed ID: 32355778
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Attenuate LPS-Induced ARDS by Modulating Macrophage Polarization Through Inhibiting Glycolysis in Macrophages.
Deng H; Wu L; Liu M; Zhu L; Chen Y; Zhou H; Shi X; Wei J; Zheng L; Hu X; Wang M; He Z; Lv X; Yang H
Shock; 2020 Dec; 54(6):828-843. PubMed ID: 32433208
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases.
Alcaraz MJ; Compañ A; Guillén MI
Cells; 2019 Dec; 9(1):. PubMed ID: 31906087
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice.
Xian P; Hei Y; Wang R; Wang T; Yang J; Li J; Di Z; Liu Z; Baskys A; Liu W; Wu S; Long Q
Theranostics; 2019; 9(20):5956-5975. PubMed ID: 31534531
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes.
Mansouri N; Willis GR; Fernandez-Gonzalez A; Reis M; Nassiri S; Mitsialis SA; Kourembanas S
JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31581150
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cell-Derived Extracellular Vesicles Alleviate Acute Lung Injury Via Transfer of miR-27a-3p.
Wang J; Huang R; Xu Q; Zheng G; Qiu G; Ge M; Shu Q; Xu J
Crit Care Med; 2020 Jul; 48(7):e599-e610. PubMed ID: 32317602
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS.
Dutra Silva J; Su Y; Calfee CS; Delucchi KL; Weiss D; McAuley DF; O'Kane C; Krasnodembskaya AD
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33334945
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
Pocsfalvi G; Mammadova R; Ramos Juarez AP; Bokka R; Trepiccione F; Capasso G
Kidney Blood Press Res; 2020; 45(5):661-670. PubMed ID: 32957112
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19?
Khalaj K; Figueira RL; Antounians L; Lauriti G; Zani A
J Extracell Vesicles; 2020 Aug; 9(1):1795365. PubMed ID: 32944185
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
Kumar S; Zhi K; Mukherji A; Gerth K
Viruses; 2020 Apr; 12(5):. PubMed ID: 32357553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
